COVID-19 Treatments Opening to High-risk Patients in UK via NHS

COVID-19 Treatments Opening to High-risk Patients in UK via NHS

314236

COVID-19 Treatments Opening to High-risk Patients in UK via NHS

People in the U.K. at highest risk of becoming seriously ill from COVID-19 — including those with cystic fibrosis (CF) — starting on Dec. 16 will have access to medications that can lessen the risk of severe disease through the country’s National Health Service (NHS). Two medications will be available: molnupiravir (sold under the brand name Lagevrio, among others), an oral small molecule developed by Merck that is designed to reduce the ability of SARS-CoV-2 (the…

You must be logged in to read/download the full post.